Do We Need Evidence-Based Medicine in the Field of Venous Diseases?

Perspectives in Vascular Surgery and Endovascular Therapy

Volumn 16, Issue 2, 2004, Pages 129-133

  Gloviczki, Peter ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84990386161     PISSN: 15310035     EISSN: None     Source Type: Journal    
DOI: 10.1177/153100350401600213     Document Type: Article

References (27)

1. Sackett DL, Rosenberg WMC, Gray JAM, et al. Evidence based medicine: What it is and what it isn't. BMJ. 312: 71-72, 1996.
2. Harris RP, Helfand M, Woolf SH, et al, Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: A review of the process. Amer J Prev Med 20: 21-35, 2001.
3. Grimes DA, Schulz KF. An overview of clinical research: The lay of the land. Lancet 359: 57-61, 2002.
4. Devereaux PJ, Yusuf S. The evolution of the randomized controlled trial and its role in evidencebased decision making. J Int Med 254: 105-113, 2003.
5. Schunemann HJ, Best D, Vist G, et al, GRADE Working Group. Letters, numbers, symbols and words: How to communicate grades of evidence and recommendations. Can Med Assoc J 169: 677-680, 2003.
6. Brand FN, Dannenberg AL, Abbott RD, et al. The epidemiology of varicose veins: The Framingham study. Am J Prev Med 4: 99-101, 1988.
7. Heit JA, Rooke TW, Silverstein MD, et al. Trends in the incidence of venous stasis syndrome and venous ulcer: A 25-year population-based study. J Vasc Surg 33: 1022-1027, 2001.
8. Korn P, Patel ST, Heller JA, et al. Why insurers should reimburse for compression stockings in patients with chronic venous stasis. J Vasc Surg 35: 950-957, 2002.
9. Nicolaides AN. The Cardiovascular Disease Educational and Research Trust. The European Society of Vascular Surgery. The International Angiology Scientific Activity Congress Organization. The International Union of Angiology. The Union Internationale de Phlebologie at the Abbaye des Vaux de Cernay. Investigation of chronic venous insufficiency: A consensus statement (France, March 5-9, 1997). Circulation 102: E126-E163, 2000.
10. Porter JM, Moneta GL and an International Consensus Committee on Chronic Venous Disease. Reporting standards in venous disease: An update. J Vasc Surg 21: 635-645, 1995.
11. Nicolaides AN and the Ad Hoc Committee of the American Venous Forum: Classification and grading of chronic venous disease in the lower limbs. A consensus statement. In Handbook of Venous Disorders: Guidelines of the American Venous Forum, 2nd ed ( Gloviczki P, Yao JST eds). London: Arnold Publ, 2001, pp 521-525.
12. Rutherford RB, Padberg FT Jr, Comerota AJ, et al. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg 2000; 31: 1307-1312.
13. Allegra C, Antignani PL, Bergan JJ, et al, and the International Union of Phlebology Working Group. The “C” of CEAP: Suggested definitions and refinements: An International Union of Phlebology conference of experts. J of Vasc Surg 37: 129-131, 2003.
14. Coleridge Smith PD. From skin disorders to venous leg ulcers: Pathophysiology and efficacy of Daflon 500 mg in ulcer healing Angiology 54(suppl 1):S45-S50, 2003.
15. Nicolaides AN. From symptoms to leg edema: Efficacy of Daflon 500 mg. Angiology 54(suppl 1):S33-S44, 2003.
16. Lyseng-Williamson KA. Perry CM. Micronised purified flavonoid fraction: A review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs 63(1):71-100, 2003.
17. Handbook of Venous Disorders: Guidelines of the American Venous Forum. 2nd ed ( Gloviczki P, Yao JST, eds). London: Arnold Publ, 2001.
18. Kurz X, Kahn SR, Abenhaim L, et al. Chronic venous disorders of the leg: Epidemiology, outcomes, diagnosis and management. Summary of an evidencebased report of the VEINES* task force. Int Angiol 18: 83-102, 1998.
19. Gloviczki P, Bergan JJ, Rhodes JM, et al, and the North American Study Group. Mid-term results of endoscopic perforator vein interruption for chronic venous insufficiency: Lessons learned from the North American Subfascial Endoscopic Perforator Surgery Registry. J Vasc Surg 29: 498-502, 1999.
20. Menawat SS, Gloviczki P, Bergan JJ, et al. Results of the North American Subfascial Endoscopic Perforator Surgery (NASEPS) registry in Handbook of Venous Disorders: Guidelines of the American Venous Forum, 2nd ed ( Gloviczki P, Yao JST, eds) London: Arnold Publ, 2001, pp 241-257.
21. Merchant RF. DePalma RG. Kabnick LS. Endovascular obliteration of saphenous reflux: A multicenter study. J Vasc Surg 35: 1190-1196, 2002.
22. TenBrook JA, lafrati M, O'Donnell TF, et al. Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery. J Vasc Surg 39: 583-589, 2004.
23. Coleridge-Smith PD. The drug treatment of chronic venous insufficiency and venous ulceration. In Handbook of Venous Disorders: Guidelines of the American Venous Forum, 2nd ed ( Gloviczki P, Yao JST, eds). London: Arnold Publ, 2001, pp 309-321.
24. Danielsson G. Jungbeck C. Peterson K. Norgren L. A randomised controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease. European J Vasc Endovasc Surg 23(1):73-76, 2002.
25. Pierik EG, van Urk H, Hop WC, et al. Endoscopic versus open subfascial division of incompetent perforating veins in the treatment of venous leg ulceration: A randomized trial. J Vasc Surg 26: 1049-1054, 1997.
26. Lurie F, Creton D, Eklof B, et al. Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study). J Vasc Surg 38: 207-217, 2003.
27. Haynes RB, Devereaux PJ, Guyatt GH. Physicians' and patients' choices in evidence based practice. BMJ 324: 1350-1350, 2002.